(2-amino-5-chlorophenyl)-(3-chlorophenyl)methanone | 5625-08-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2-amino-5-chlorophenyl)-(3-chlorophenyl)methanone
• 英文别名: (2-amino-5-chlorophenyl)(3-chlorophenyl)methanone；2-amino-5-chloro-3'-chloro-benzophenone
• CAS: 5625-08-1
• 化学式: C₁₃H₉Cl₂NO
• 分子量: 266.127
• InChiKey: IEGJLMOKNJZBTH-UHFFFAOYSA-N

物化性质

• 熔点：
  107-109 °C
• 沸点：
  453.6±45.0 °C(Predicted)
• 密度：
  1.373±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (2-amino-5-chlorophenyl)-(3-chlorophenyl)methanone 在 sodium hydride 、 potassium carbonate 、 potassium hydroxide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 16.0h， 生成 6-chloro-4-(3-chloro-phenyl)-2-diethylamino-quinoline-3-carboxylic acid tert-butyl ester
  参考文献：
  名称：

  [EN] NEW ARYL-QUINOLINE DERIVATIVES
  [FR] NOUVEAUX DÉRIVÉS D'ARYLQUINOLÉINE

  摘要：

  本发明提供了具有通用公式(I)的新颖化合物，其中R1、R2、R3、R4、R5、R6和n如本文所述，包括这些化合物的组合物以及使用这些化合物的方法。

  公开号：

  WO2013064465A1
• 作为产物：
  描述：

  3-氯苯甲酸 在 氯化亚砜 、 zinc(II) chloride 作用下， 反应 10.0h， 生成 (2-amino-5-chlorophenyl)-(3-chlorophenyl)methanone
  参考文献：
  名称：

  Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors

  摘要：

  A new series of substituted 2-sulfonyphenyl-3-phenyl-indole derivatives were synthesized and evaluated for their ability to inhibit COX-2 and COX-lenzymes. Most of the compounds synthesized were found to be highly potent and selective inhibitors of COX-2. This work led to the discovery of 2-aminosulfonylphenyl-3-phenyl-indole 5a which possesses higher activity and selectivity for COX-2 than Celecoxib both in vitro and in vivo. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(03)00046-4

文献信息

• Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof
  申请人：——

  公开号：US20040058977A1

  公开（公告）日：2004-03-25

  The present invention relates to sulfonyl-containing 2,3-diarylindole, especially to new compounds of general Formula, to a preparation method for their preparation, to pharmaceutical compositions containing said compound, and to the medical use thereof in the treatment of diseases relating to the inhibition of cyclooxygenase-2 (COX-2).

  本发明涉及含砜基的2,3-二芳基吲哚，特别涉及一般式的新化合物，其制备方法，含有该化合物的药物组合物，以及在治疗与环氧合酶-2（COX-2）抑制有关的疾病中的医疗用途。
• ARYL-QUINOLINE DERIVATIVES
  申请人：Hoffmann-La Roche Inc.

  公开号：US20130116234A1

  公开（公告）日：2013-05-09

  The invention provides novel compounds having the general formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and n are as described herein, compositions including the compounds and methods of using the compounds. The present compounds are useful as fatty-acid binding protein (FABP) 4 and/or 5 inhibitors and may be used for the treatment or prophylaxis of lipodystrophy, type 2 diabetes, dyslipidemia, atherosclerosis, liver diseases involving inflammation, steatosis and/or fibrosis, such as non-alcoholic fatty liver disease, in particular non-alcoholic steatohepatitis, metabolic syndrome, obesity, chronic inflammatory and autoimmune inflammatory diseases.

  本发明提供了具有通用公式 (I) 的新颖化合物，其中 R1、R2、R3、R4、R5、R6 和 n 如本文所述，包括这些化合物的组合物和使用这些化合物的方法。本发明的化合物作为脂肪酸结合蛋白（FABP）4和/或5的抑制剂非常有用，并且可用于治疗或预防脂肪营养不良、2型糖尿病、血脂异常、动脉硬化、涉及炎症、脂肪变性和/或纤维化的肝脏疾病，如非酒精性脂肪肝病，尤其是非酒精性脂肪肝炎，代谢综合征，肥胖，慢性炎症和自身免疫性炎症疾病。
• Asymmetric Reduction of 2-Aminobenzophenone Using Yeast, Rhodosporidium toruloides.
  作者：Masahiro KATO、Kazuo SASAHARA、Kiyoshige OCHI、Hiroyuki AKITA、Takeshi OISHI

  DOI：10.1248/cpb.39.2498

  日期：——

  (±)-N-Isonicotinoyl-2-amino-5-chlorobenzhydrol (1) is a rice plant growth regulator which shortens the second leaf sheaths. One of the enantiomers, (S)-1, was obtained by microbiological asymmetric reduction of 2-amino-5-chlorobenzophenone using Rhodosporidium toruloides followed by isonicotinoylation. Several substituted benzhydrol derivatives were also prepared by use of the same biological method and converted to N-isonicotinoyl compounds. The growth-regulating activities of these compounds were evaluated.

  (±)-N-异烟酰基-2-氨基-5-氯苯基醇 (1) 是一种水稻植物生长调节剂，可缩短第二片叶鞘。通过使用红酵母Rhodosporidium toruloides对2-氨基-5-氯苯酮进行微生物不对称还原，得到了其中一个对映体(S)-1，随后进行异烟酰化。还通过相同的生物方法制备了几种取代的苯基醇衍生物，并转化为N-异烟酰基化合物。对这些化合物的生长调节活性进行了评估。
• New Aryl-Quinoline Derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US20160060270A1

  公开（公告）日：2016-03-03

  The invention provides novel compounds having the general formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and n are as described herein, compositions including the compounds and methods of using the compounds. The present compounds are useful as fatty-acid binding protein (FABP) 4 and/or 5 inhibitors and may be used for the treatment or prophylaxis of lipodystrophy, type 2 diabetes, dyslipidemia, atherosclerosis, liver diseases involving inflammation, steatosis and/or fibrosis, such as non-alcoholic fatty liver disease, in particular non-alcoholic steatohepatitis, metabolic syndrome, obesity, chronic inflammatory and autoimmune inflammatory diseases.

  本发明提供了具有通式（I）的新化合物，其中R1、R2、R3、R4、R5、R6和n如本文所述，包括该化合物的组合物和使用该化合物的方法。本化合物可用作脂肪酸结合蛋白（FABP）4和/或5的抑制剂，并可用于治疗或预防脂肪萎缩、2型糖尿病、血脂异常、动脉粥样硬化、涉及炎症、脂肪变性和/或纤维化的肝脏疾病，如非酒精性脂肪肝病，特别是非酒精性脂肪性肝炎、代谢综合征、肥胖症、慢性炎症和自身免疫性炎症性疾病。
• Aryl-quinoline derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US09199938B2

  公开（公告）日：2015-12-01

  The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6 and n are as described herein, compositions including the compounds and methods of using the compounds. The present compounds are useful as fatty-acid binding protein (FABP) 4 and/or 5 inhibitors and may be used for the treatment or prophylaxis of lipodystrophy, type 2 diabetes, dyslipidemia, atherosclerosis, liver diseases involving inflammation, steatosis and/or fibrosis, such as non-alcoholic fatty liver disease, in particular non-alcoholic steatohepatitis, metabolic syndrome, obesity, chronic inflammatory and autoimmune inflammatory diseases.

  本发明提供了具有一般式（I）的新化合物，其中R1、R2、R3、R4、R5、R6和n如本文所述，包括该化合物的组合物和使用该化合物的方法。目前的化合物可用作脂肪酸结合蛋白（FABP）4和/或5的抑制剂，并可用于治疗或预防脂肪萎缩症、2型糖尿病、血脂异常、动脉粥样硬化、涉及炎症、脂肪变性和/或纤维化的肝脏疾病，例如非酒精性脂肪肝病，特别是非酒精性脂肪性肝炎，代谢综合征、肥胖症、慢性炎症和自身免疫性炎症性疾病。